Experimental fat embolism induces urine 2,3-dinor-6-ketoprostaglandin F(1α) and 11-dehydrothromboxane B2 excretion in pigs

Critical Care Medicine

Volumn 25, Issue 7, 1997, Pages 1215-1221

  Rautanen, Markku ^a,d   Gullichsen, Eero ^a   Riutta, Asko ^b   Kuttila, Kari ^a   Mucha, Istvan ^c   Nelimarkka, Olavi ^a   Niinikoski, Juha ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^d KANTA HÄME CENTRAL HOSPITAL   (Finland)

Author keywords

2,3 dinor 8 ketoprostaglandin F(1 ) 11 dehydrothromboxane B2; Fat embolism; Hypoxemia; Lung injury; Prostacyclin; Prostaglandin metabolites; Pulmonary hemodynamics; Thromboxane A2; Vasoconstriction

Indexed keywords

11 OXOTHROMBOXANE B2; 2,3 DINOR 6 OXOPROSTAGLANDIN F1 ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL VENOUS PRESSURE; FAT EMBOLISM; FEMALE; LUNG ARTERY PRESSURE; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROSTAGLANDIN URINE LEVEL; PROTEIN SYNTHESIS REGULATION; PULMONARY HYPERTENSION; SWINE;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMALS; ASPIRIN; CYCLOOXYGENASE INHIBITORS; EMBOLISM, FAT; EPOPROSTENOL; EVALUATION STUDIES; HEMODYNAMIC PROCESSES; HYPERTENSION, PULMONARY; LUNG DISEASES; RANDOM ALLOCATION; SWINE; THROMBOXANE A2; THROMBOXANE B2;

EID: 0030792411     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199707000-00025     Document Type: Article

References (44)

1. Peltier LF: The classic fat embolism. An appraisal of the problem. Clin Orthop 1984; 187:3-17
2. Fabian TC, Hoots AV, Stanford DS, et al: Fat embolism syndrome. Prospective evaluation in 92 fracture patients. Crit Care Med 1990; 18:42-46
3. Demling RH: Role of prostaglandins in acute pulmonary microvascular injury. Ann NY Acad Sci 1982; 384:517-526
4. Henderson W: Eicosanoids and lung inflammation. Am Rev Respir Dis 1987; 135:1176-1185
5. Hammarström S, Falardeau P: Resolution of prostaglandin endoperoxide synthase and thromboxane synthase in human platelets. Proc Natl Acad Sci U S A 1977; 74:3691-3695
6. 2. Science 1976; 193:1135-1137
7. Bunting S, Gryglewski R, Moncada S, et al: Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation. Prostaglandins 1976; 12:897-913
8. Michiels C, Arnould T, Knott I, et al: Stimulation of prostaglandin synthesis by human endothelial cells exposed to hypoxia. Am J Physiol 1993; 264: C866-C874
9. Roy L, Knapp HR, Robertson RM, et al: Endogenous biosynthesis of prostacyclin during cardiac catheterization and angiography in man. Circulation 1985; 71:434-440
10. Gitin TA, Seidel T, Cera PJ, et al: Pulmonary microvascular fat: The significance? Crit Care Med 1993; 21:673-677
11. 1α for determination with radioimmunoassay. Anal Biochem 1994; 220:1-9
12. 2 for reliable determination with radioimmunoassay. Anal Biochem 1992; 202:299-305
13. Severinghaus JW: Blood gas calculator. J Appl Physiol 1966; 21:1108-1116
14. Peltier LF: Fat embolism. A perspective. Clin Orthop 1988; 232:263-270
15. Watson AJ: Genesis of fat emboli. J Clin Pathol 1970; 23(Suppl 4):132-142
16. Derks CM, Peters RM: The effect of shock and fat embolus on pulmonary mechanics and gas exchange. Surg Gynecol Obstet 1974; 138:413-416
17. Burhop KE, Selig WM, Beeler DA, et al: Effect of heparin on increased pulmonary microvascular permeability after bone marrow embolism in awake sheep. Am Rev Respir Dis 1978; 136:134-141
18. Yamaguchi K, Mori M, Kawai A, et al: Regulation of blood flow in pulmonary microcirculation by vasoactive arachidonic acid metabolites - Analysis in acute lung injury. Adv Exp Med Biol 1994; 345:113-120
19. Selig WM, Burhop KE, Malik AB: Role of lipids in bone marrow-induced pulmonary edema. J Appl Physiol 1987; 62:1068-1075
20. Byrick RJ, Mullen JB, Wong PY, et al: Prostanoid production and pulmonary hypertension after fat embolism are not modified by methylprednisolone. Can J Anaesth 1991; 38:660-667
21. Deby-Dupont G, Braun M, Lamy M, et al: Thromboxane and prostacyclin release in adult respiratory distress syndrome. Intensive Care Med 1987; 13: 167-174
22. Brash AR, Jackson EK, Saggese CA, et al: Metabolic disposition of prostacyclin in humans. J Pharmacol Exp Ther 1983; 226:78-87
23. 2 in man. Prostaglandins 1993; 45: 401-411
24. Jolin A, Bjertnäs L: Hypoxic pulmonary vasoconstriction in the adult respiratory distress syndrome. Acta Anaesthesiol Scand 1991; 35(Suppl 95): 40-54
25. Hoshino Y, Morrison KJ, Vanhoutte PM: Mechanisms of hypoxic vasoconstriction in the canine isolated pulmonary artery: Role of endothelium and sodium pump. Am J Physiol 1994; 267: L120-L127
26. Kraft SA, Fujishima S, Mcguire GP, et al: Effect of blood and albumin on pulmonary hypertension and edema in perfused rabbit lungs. J Appl Physiol 1995; 78:499-504
27. Lee CC, Sugerman HJ, Tatum JL, et al: Effects of ibuprofen on a pig Pseudomonas ARDS model. J Surg Res 1986; 40:438-444
28. 2. J Appl Physiol 1996; 80:191-197
29. Radermacher P, Santak B, Wust HJ, et al: Prostacyclin for the treatment of pulmonary hypertension in the adult respiratory distress syndrome: Effects on pulmonary capillary pressure and ventilation-perfusion distributions. Anesthesiology 1990; 72:238-244
30. Snapper JR, Hutchinson AA, Ogletree ML: Effects of cyclooxygenase inhibitors on the alterations in lung mechanics caused by endotoxemia in the unanesthetized sheep. J Clin Invest 1983; 72:63-76
31. Walmrath D, Pilch J, Scharmann M, et al: Severe VA/Q mismatch in perfused lungs evoked by sequential challenge with endotoxin and E. coli hemolysin. J Appl Physiol 1994; 76:1020-1030
32. Christman BW, McPherson CD, Newman JH, et al: An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. New Engl J Med 1992; 9:70-75
33. 2 in urine. Prostaglandins 1989; 38:157-170
34. Husted SE, Kristensen SD, Vissinger H, et al: Intravenous acetylsalicylic acid-dose related effects of platelet function and fibrinolysis in healthy males. Thromb Haemost 1992; 68: 226-229
35. Böger RH, Bode-Böger SM, Gutzki FM, et al: Rapid and selective inhibition of platelet aggregation and thromboxane formation by intravenous low dose aspirin in man. Clin Sci 1993; 84:517-524
36. Ritter JM, Cockcroft JR, Doktor HS, et al: Differential effect of aspirin on thromboxane and prostaglandin biosynthesis in man. Br J Clin Pharmacol 1989; 28:573-579
37. Leeman M, Lejeune P, Hallemans R, et al: Effects of increased pulmonary vascular tone on gas exchange in canine oleic acid pulmonary edema. J Appl Physiol 1988; 65:662-668
38. 2 formation on early pulmonary hypertension induced by oleic acid administration in sheep. Thromb Res 1990; 58:35-45
39. Thies SD, Corbin RS, Goff CD, et al: Thromboxane receptor blockade improves oxygenation in an experimental model of acute lung injury. Ann Thorac Surg 1996; 61:1453-1457
40. Kawaguchi H, Shoki M, Iizuka K, et al: Phospholipid metabolism and prostacyclin synthesis in hypoxic myocytes. Biochim Biophys Acta 1991; 1094: 161-167
41. 2 formation of human platelets by hypoxia. Prostaglandins Leukotrienes and Medicine 1987; 29:49-59
42. Tsao PS, Lewis NP, Alpert S, et al: Exposure to shear stress alters endothelial adhesiveness. Role of nitric oxide. Circulation 1995; 92:3513-3519
43. Slack SM, Jennings LK, Turitto VT: Platelet size distribution measurements as indicators of shear stress-induced platelet aggregation. Ann Biomed Eng 1994; 22:653-659
44. Cattaneo M, Zighetti ML, Lombardi R, et al: Role of ADP in platelet aggregation at high shear: Studies in a patient with congenital defect of platelet responses to ADP. Br J Haematol 1994; 88:826-829